Hisashi Kosaka

1.6k total citations
72 papers, 417 citations indexed

About

Hisashi Kosaka is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hisashi Kosaka has authored 72 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 34 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hisashi Kosaka's work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Pancreatic and Hepatic Oncology Research (24 papers) and Gallbladder and Bile Duct Disorders (21 papers). Hisashi Kosaka is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Pancreatic and Hepatic Oncology Research (24 papers) and Gallbladder and Bile Duct Disorders (21 papers). Hisashi Kosaka collaborates with scholars based in Japan, Vietnam and United States. Hisashi Kosaka's co-authors include Sohei Satoi, Satoshi Hirooka, Tomohisa Yamamoto, Yoichi Matsui, So Yamaki, Masaki Kaibori, Mitsugu Sekimoto, Hiroaki Yanagimoto, Kosuke Matsui and Jiro Fujimoto and has published in prestigious journals such as The American Journal of Surgery, Journal of the American College of Surgeons and Annals of Surgical Oncology.

In The Last Decade

Hisashi Kosaka

59 papers receiving 412 citations

Peers

Hisashi Kosaka
Hisashi Kosaka
Citations per year, relative to Hisashi Kosaka Hisashi Kosaka (= 1×) peers Naoya İmamura

Countries citing papers authored by Hisashi Kosaka

Since Specialization
Citations

This map shows the geographic impact of Hisashi Kosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisashi Kosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisashi Kosaka more than expected).

Fields of papers citing papers by Hisashi Kosaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisashi Kosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisashi Kosaka. The network helps show where Hisashi Kosaka may publish in the future.

Co-authorship network of co-authors of Hisashi Kosaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hisashi Kosaka. A scholar is included among the top collaborators of Hisashi Kosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisashi Kosaka. Hisashi Kosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsui, Kosuke, Hideyuki Matsushima, Hidekazu Yamamoto, et al.. (2025). Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right‐Sided Major Hepatectomy. Annals of Gastroenterological Surgery. 10(1). 229–240. 1 indexed citations
2.
Matsui, Kosuke, Hisashi Kosaka, Hideyuki Matsushima, et al.. (2025). Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy. Oncology. 104(2). 113–124.
3.
Shinkawa, Hiroji, Daiju Ueda, Masaki Kaibori, et al.. (2025). Individualized Prognostication Based on Deep‐Learning Models Using Computed Tomography as an Imaging Biomarker After Hepatocellular Carcinoma Resection. Hepatology Research. 56(2). 204–213.
4.
Yamaguchi, Tomohiro, Hisashi Kosaka, Katsunori Yoshida, et al.. (2024). Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib. Molecular and Clinical Oncology. 21(3). 63–63. 1 indexed citations
5.
Kaibori, Masaki, Kengo Yoshii, Kosuke Matsui, et al.. (2023). The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy. Cancers. 15(11). 2905–2905. 1 indexed citations
6.
Yamamoto, Hidekazu, et al.. (2023). Efficacy and Safety of Liver Resection in Super Elderly Patients with Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention. 24(3). 1089–1094. 1 indexed citations
7.
Shinkawa, Hiroji, Masaki Kaibori, Daijiro Kabata, et al.. (2023). Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Surgical Endoscopy. 38(2). 757–768. 2 indexed citations
8.
Ota, Masato, Koji Komeda, Hiroya Iida, et al.. (2023). The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology. 30(5). 2807–2815. 1 indexed citations
10.
Kaibori, Masaki, Hisashi Kosaka, Kosuke Matsui, et al.. (2022). Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model. Nanomaterials. 12(8). 1364–1364. 7 indexed citations
11.
Kaibori, Masaki, Kengo Yoshii, Hisashi Kosaka, et al.. (2022). Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study. Cancers. 14(21). 5459–5459. 3 indexed citations
13.
Kaibori, Masaki, Kengo Yoshii, Kosuke Matsui, et al.. (2022). Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy. Cancers. 14(21). 5292–5292. 8 indexed citations
14.
Okamoto, Yoshiharu, Hisashi Kosaka, Akiko Suganami, et al.. (2022). Inhibitory effects and gene expression analysis of chemotherapeutic photodynamic therapy by using a liposomally formulated indocyanine green derivative. Photodiagnosis and Photodynamic Therapy. 39. 102961–102961. 6 indexed citations
15.
Kaibori, Masaki, Hideyuki Matsushima, Morihiko Ishizaki, et al.. (2021). Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma. Cancers. 13(4). 842–842. 11 indexed citations
16.
Kosaka, Hisashi, Masaki Kaibori, Daniel I. Chu, Arthur F. Stucchi, & Mitsugu Sekimoto. (2021). Role of Substance P–Dependent Chemotactic Signaling in Postoperative Adhesion Formation. Journal of Surgical Research. 270. 49–57. 3 indexed citations
17.
Ishizaki, Morihiko, Masaki Kaibori, Hideyuki Matsushima, et al.. (2021). Long-term complete response to lenvatinib in a patient with unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 14(6). 1700–1705.
18.
Matsui, Yoichi, Satoshi Hirooka, So Yamaki, et al.. (2018). Use of a piece of free omentum to prevent bile leakage after subtotal cholecystectomy. Surgery. 164(3). 419–423. 22 indexed citations
19.
Satoi, Sohei, Tomohisa Yamamoto, Hiroaki Yanagimoto, et al.. (2018). Does modified Blumgart anastomosis without intra-pancreatic ductal stenting reduce post-operative pancreatic fistula after pancreaticojejunostomy?. Asian Journal of Surgery. 42(1). 343–349. 19 indexed citations
20.
Kosaka, Hisashi, Nobukazu Kuroda, Koichiro Ohashi, et al.. (2012). Primary inflammatory myofibroblastic tumor of the liver: case report. Kanzo. 53(5). 272–277. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026